Studied Subjects and Serum TFR Levels
| Diagnosis . | Group . | TFR mg/L . | ||
|---|---|---|---|---|
| . | . | n . | Mean ± SD . | Range . |
| DIS | 1 | 33 | 2.60 ± 0.84 | 1.20-4.80 |
| IDE | 2 | 55 | 2.96 ± 0.83 | 1.50-4.94 |
| HIDE | 4 | 5.01 ± 0.84 | 4.40-6.20 | |
| MIDE | 3 | 17 | 3.93 ± 1.77 | 2.10-8.40 |
| MHIDE | 8 | 8.01 ± 2.45 | 3.80-24.50 | |
| NIDA | 53 | 4.49 ± 2.16 | 2.10-14.70 | |
| HIDA | 4 | 33 | 6.73 ± 5.18 | 1.60-26.50 |
| MIDA | 63 | 5.94 ± 4.60 | 1.90-36.20 | |
| MHIDA | 5 | 173 | 14.00 ± 10.60 | 3.90-72.00 |
| Controls | 6 | 88 | 2.43 ± 0.67 | 1.00-3.70 |
| Diagnosis . | Group . | TFR mg/L . | ||
|---|---|---|---|---|
| . | . | n . | Mean ± SD . | Range . |
| DIS | 1 | 33 | 2.60 ± 0.84 | 1.20-4.80 |
| IDE | 2 | 55 | 2.96 ± 0.83 | 1.50-4.94 |
| HIDE | 4 | 5.01 ± 0.84 | 4.40-6.20 | |
| MIDE | 3 | 17 | 3.93 ± 1.77 | 2.10-8.40 |
| MHIDE | 8 | 8.01 ± 2.45 | 3.80-24.50 | |
| NIDA | 53 | 4.49 ± 2.16 | 2.10-14.70 | |
| HIDA | 4 | 33 | 6.73 ± 5.18 | 1.60-26.50 |
| MIDA | 63 | 5.94 ± 4.60 | 1.90-36.20 | |
| MHIDA | 5 | 173 | 14.00 ± 10.60 | 3.90-72.00 |
| Controls | 6 | 88 | 2.43 ± 0.67 | 1.00-3.70 |